211915-06-9
Chemical Structure
Dabigatran etexilate
Synonym(s): BIBR 1048
- CAS No.: 211915-06-9
- Formula:C34H41N7O5
- Molecular Weight:627.73
IUPAC Name: ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate
InChIKey: KSGXQBZTULBEEQ-UHFFFAOYSA-N
SMILES: O=C(N(C1=NC=CC=C1)CCC(OCC)=O)C2=CC=C3C(N=C(N3C)CNC4=CC=C(C(NC(OCCCCCC)=O)=N)C=C4)=C2
Biological Activity: Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dabigatran etexilate | 99.92% | Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dabigatran etexilate (Standard) | ≥98% | Dabigatran etexilate (Standard) is the analytical standard of Dabigatran etexilate. This product is intended for research and analytical applications. Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dabigatran etexilate-d11 | Dabigatran etexilate-d11 (BIBR 1048-d11) is the deuterium labeled Dabigatran etexilate (HY-10274). Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran (a direct inhibitor of thrombin). Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dabigatran etexilate-d13 | 99.28% | Dabigatran etexilate-d13 is the deuterium labeled Dabigatran etexilate. Dabigatran etexilate (BIBR 1048) is an orally active proagent of Dabigatran. Dabigatran etexilate has anticoagulant effects and is used for the prophylaxis of venousthromboembolism and stroke due to atrial fibrillation. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.98
HY-Z4698Dabigatran impurity 52 -
Similarity Score 0.95
HY-Z4788Dabigatran impurity 3 -
Similarity Score 0.95
HY-Z4213Dabigatran impurity 9 -
Similarity Score 0.95
HY-10274ARDabigatran etexilate mesylate (Standard) -
Similarity Score 0.93
HY-W004360BIBR 1087 SE -
Similarity Score 0.92
HY-21609Dabigatran impurity 8 -
Similarity Score 0.91
HY-Z4699Dabigatran impurity 80 -
Similarity Score 0.90
HY-Z4697Dabigatran impurity 4 -
Similarity Score 0.89
HY-Z3076Dabigatran impurity 47 -
Explore the MedChemAI to find more analogs
